• vcard
D 816.572.4645
F 816.753.1536
  • Education
    • J.D., University of Missouri, 2005, Missouri Law Review, Note and Comment Editor
    • B.S., summa cum laude, University of Missouri, 2001

From a company’s inception to its exit and everything in between, Cortney Mendenhall represents business clients through all aspects of their life cycle. As an attorney focused on the life sciences sector, Cortney has significant experience representing clients in the human health, animal health, and biosecurity industries. In that regard, she works closely with the other groups within the firm to provide fully integrated representation to her clients. Cortney has nearly 10 years of experience representing companies in corporate finance, mergers and acquisitions, joint ventures, licensing, and other strategic transactions.

She often advises companies with respect to:

  • Entity selection and formation
  • Negotiation of shareholder and buy-sell agreements
  • Negotiation and execution of initial and subsequent rounds of equity financing
  • Negotiation of licensing agreements, technology transfer agreements, material transfer agreements, employment and consulting agreements, services agreements, clinical trial agreements, and other commercial agreements
  • Structuring and negotiation of exit transactions

Cortney uses a pragmatic approach to representing clients by learning about their business, legal, and financial goals at the outset in order to specifically tailor her representation for each one.

  • Represented a specialty pharmaceutical company in its $100 million sale to a publicly held company.
  • Represented an animal health biopharmaceutical company in a series of successful private placements of its securities, totaling nearly $30 million. Helped secure significant local income tax credits for investors with respect to such private placements.
  • Led a team of attorneys that acted as specialty regulatory, intellectual property, and corporate counsel to an animal health biopharmaceutical company with respect to its initial public offering.
  • Launched a partnership with an area life sciences company incubator and law school in order to provide corporate and intellectual property legal services to young life sciences companies on a pro bono basis, while providing "real world" transactional experience for law students.
  • Represented a medical device company in its corporate restructuring.
  • Represented a medical mobile application developer in the private placement of its securities.
eAlerts Alerts
March 18, 2016
Publications & Presentations
American Bankruptcy Institute Technology & Intellectual Property Newsletter, Vol. 13, No. 1
March 2016